Adherence problems in psychiatry arise due to illness-related restrictions, side effects and psychosocial, economic and cultural burdens. Low insight into the illness, affective instability and cognitive deficits make adherence to treatment even more difficult. Structured, individually tailored treatment, modern pharmacotherapy and participatory decision-making can improve adherence in the long term.
Autoren
- Dr. Ulf Blanke
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Participation of the patient
Adherence in psychiatry
- Psychooncology
Communication as the key to therapy adherence
- From symptom to diagnosis
Renal cell carcinoma
- Lipid management: ESC/EAS guideline update 2025
New recommendations on CVD risk classification, lipid lowering in statin intolerance and hoFH
- Chronically active MS lesions
New paradigm in the diagnosis and treatment of multiple sclerosis
- Participation of the patient
Adherence in psychiatry
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Eosinophilic esophagitis